Straight to content

Overpriced

Drugs Developed with Dutch Public Funding

Posted in category:
Publication
Written by:
Written by: Irene Schipper
Written by: Esther de Haan
Written by: Roberta Cowan
Published on:

This report examines the extent of Dutch public funding of drug development, through donations, loans and/or investments. This funding occurs both directly by financing development of new medicines, and indirectly through investments made into biotech companies, but channelled through universities, public research bodies, and national and regional investment funds.

A Dutch summary of the report is available as well.

 

 

Do you need more information?

Publication

Posted in category:
Publication
Written by:
Written by: Irene Schipper
Written by: Esther de Haan
Written by: Roberta Cowan
Published on:

Related news

Don't want to miss anything?

Sign up for our newsletter and always stay up to date on information and analysis on corporate power issues.